Anzeige
Mehr »
Login
Freitag, 17.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
659 Leser
Artikel bewerten:
(2)

Pre-IPO Marketplace InvestX Expands Leadership Team, Appointing Jonathan A. Clark as President, USA and Dan Sanders as Executive Vice President, Private Markets

Finanznachrichten News

Industry Veterans Bolster their Marketplace Growth

NEW YORK, NY / ACCESSWIRE / March 3, 2022 / InvestX Capital Ltd. ("InvestX" or the "Company"), a leading private equity marketplace that empowers broker-dealers to invest in pre-IPO companies through its state of the art platform GEM (Growth Equity Marketplace), today announced the expansion of its executive leadership team with the appointments of Jonathan A. Clark, as President, USA, and Dan Sanders, as Executive Vice President, Private Markets. Together, these leaders will support the company's growth and further enhance its ability to provide sell-side broker-dealers access to the growing private markets.

"We are thrilled to welcome industry veterans Jonathan and Dan to the InvestX team," said Marcus New, Founder and CEO. "They each bring years of experience, skills, integrity, and proven leadership that will help us continue to make a meaningful impact in the wealth management industry and to our broker-dealer clients as we work towards the electronification and democratization of the process for investing in pre-IPO companies. Together, these leaders will support the company's growth and further enhance its ability to provide sell-side broker-dealers access to the insatiable demand for this asset class."

Jonathan A. Clark, President, USA

Clark will be responsible for managing InvestX's go-to-market teams, leading efforts in client success and overall US operations. He brings over 30 years of experience spanning both the buy-side and the sell-side, former Co-Head of the Equity Trading desk of BlackRock's Americas business, Clark then went on to lead Luminex where he served most recently as CEO and President, responsible for launching and leading an equity dark pool alternative trading system (ATS) focused solely on block trading, which grew significantly under his leadership.

"As the private equity market has nearly tripled in the last decade, I'm excited to be joining a company that has been dedicated to expanding access to this elusive asset class since Day 1," said Jonathan A. Clark, President, USA of InvestX. "Having been in the industry working on both the sell-side and buy-side, I was fascinated by how InvestX is solving unique challenges to investing in the private markets, offering low investment minimums and state-of-the-art trading technology. I look forward to contributing to the further growth of the company for years to come."

Dan Sanders, Executive Vice President, Private Markets

Sanders, former Head of Execution Services in the Americas for Citi, where his responsibilities included running cash sales trading, electronic execution sales, portfolio trading, and platform sales, then went on to be the Head of Business Development in the Americas for Liquidnet, a global institutional investment network that connects asset managers with liquidity, will be responsible for securing key partners across multiple industries as well as identifying new investment opportunities, including sourcing shares both directly and through a network of contacts at venture capital and private equity firms, incubators/accelerators, and more. Sanders brings more than 25 years of finance, trading, equity, technology and sales experience, and has built significant client relationships over the years.

"After years in the public equity and fixed income markets, I am eager to join the undeniable growth in the private markets, hit the ground running by working with the team to spearhead this momentum and simultaneously identify additional investment opportunities along the way to accelerate InvestX's long-term growth strategy," said Dan Sanders, Executive Vice President, Private Markets at InvestX.

In 2021, InvestX made new investments in the following notable companies: Impossible Foods, Kraken, Hootsuite, Udacity, DataStax, Scopely, Epic Games, Varo Bank, among others. Exited investments include: Palantir, AirBnB, 23andMe, SoFi, Ginkgo Bioworks and others. The company also announced a strategic investment from financial leaders Jefferies Financial Group Inc., Virtu Financial and Canaccord Genuity Group Inc., which is being used to advance its technology platform, increase back-office integration, and expand its footprint in the U.S. and Canada.

About InvestX

Launched in 2014, InvestX provides the $30 trillion dollar wealth management industry with access to the private equity asset class. InvestX empowers broker-dealers and advisors with access, liquidity, and innovation to the private equity asset class through investments in pre-IPO companies on a state-of-the-art trading platform. Sell-side firms can access unbiased information, and trade shares of institutional quality private equity, without the traditional multi-million-dollar investment minimums. InvestX is democratizing the growth equity asset class by offering real-time trading technology that provides better access, liquidity, and transparency to an antiquated process. For more information visit https://www.investx.com/.

Media Contact:

Caitlinn Riedell
Caliber Corporate Advisers
caitlinn@calibercorporateadvisers.com
(516) 547-5686

SOURCE: InvestX



View source version on accesswire.com:
https://www.accesswire.com/691455/Pre-IPO-Marketplace-InvestX-Expands-Leadership-Team-Appointing-Jonathan-A-Clark-as-President-USA-and-Dan-Sanders-as-Executive-Vice-President-Private-Markets

© 2022 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.